Excitatory amino acid modulation of lordosis in the rat.
Microinfusion of the excitatory amino acid agonist N-methyl-D-aspartate (NMDA) into the mediobasal hypothalamus (MBH) significantly reduced lordosis in estrogen plus progesterone-treated female rats at 10 min post-infusion with recovery to pretest values by 30 min (P less than .05; Wilcoxon). Microinfusion of the specific NMDA antagonist D,L2-amino-5-phosphonopentoic acid (AP-5) into the same sites was without effect on lordosis responding of fully receptive females. There was also a significant increase in the number of females vocalizing to mounts by males after infusion of NMDA but not after infusion of AP-5 into the MBH. When NMDA was infused into the preoptic area (POA) there was no effect on lordosis responding of full receptive females, but AP-5 infusion resulted in a significant inhibition of lordosis at 10 min post-infusion. There was no difference between groups in percentage of females vocalizing after drug infusion into the POA. These results suggest that increased excitatory amino acid activity in the MBH and decreased excitatory amino acid activity in the POA inhibits lordosis behavior.
McCarthy
M M
MM
Institute of Animal Behavior, Rutgers University, Newark, NJ 07012.
Curran
G H
GH
Feder
H H
HH
D015763:2-Amino-5-phosphonovalerate / Q000008:administration & dosage / Q000494:pharmacology*; D000818:Animals; D004958:Estradiol / Q000494:pharmacology*; D005260:Female; D007033:Hypothalamus, Middle / Q000187:drug effects / Q000502:physiology*; D007263:Infusions, Parenteral; D016202:N-Methylaspartate / Q000008:administration & dosage / Q000494:pharmacology*; D011187:Posture; D011301:Preoptic Area / Q000187:drug effects / Q000502:physiology*; D011374:Progesterone / Q000494:pharmacology*; D051381:Rats; D011919:Rats, Inbred Strains; D012016:Reference Values; D012726:Sexual Behavior, Animal / Q000187:drug effects*; D014828:Vocalization, Animal
D011374:Progesterone; D004958:Estradiol; D016202:N-Methylaspartate; D015763:2-Amino-5-phosphonovalerate